Karima Begriche

发表

Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity

B. Fromenty, C. Moreau, J. Massart, 2017, Journal of clinical and translational research.

Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.

D. Pessayre, B. Fromenty, A. Bado, 2008, American journal of physiology. Endocrinology and metabolism.

Drug-Induced Inhibition of Mitochondrial Fatty Acid Oxidation and Steatosis

B. Fromenty, K. Begriche, J. Massart, 2013, Current Pathobiology Reports.

Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.

B. Fromenty, M. Robin, K. Begriche, 2011, Journal of hepatology.

Drug-induced liver injury in obesity and nonalcoholic fatty liver disease.

B. Fromenty, K. Begriche, Julien Allard, 2019, Advances in pharmacology.

Chronic and low exposure to a pharmaceutical cocktail induces mitochondrial dysfunction in liver and hyperglycemia: Differential responses between lean and obese mice

B. Fromenty, K. Begriche, A. Borgne-Sanchez, 2017, Environmental toxicology.

Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

D. Pessayre, B. Fromenty, K. Begriche, 2006, Mitochondrion.

Melanocortin-3 receptors are involved in adaptation to restricted feeding

L. Heisler, A. Butler, L. K. Burke, 2012, Genes, brain, and behavior.

Genetic Dissection of the Functions of the Melanocortin-3 Receptor, a Seven-transmembrane G-protein-coupled Receptor, Suggests Roles for Central and Peripheral Receptors in Energy Homeostasis*

D. Marks, A. Butler, L. Solt, 2011, The Journal of Biological Chemistry.

Homeostastic and non-homeostatic functions of melanocortin-3 receptors in the control of energy balance and metabolism

A. Butler, K. Begriche, G. Sutton, 2011, Physiology & Behavior.

Central nervous system melanocortin‐3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle

J. Gimble, M. Tschöp, M. Hulver, 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The role of melanocortin neuronal pathways in circadian biology: a new homeostatic output involving melanocortin‐3 receptors?

A. Butler, K. Begriche, G. Sutton, 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review

B. Fromenty, K. Begriche, J. Massart, 2023, Livers.

β‐Aminoisobutyric Acid Prevents Diet‐induced Obesity in Mice With Partial Leptin Deficiency

B. Fromenty, J. Massart, P. Lettéron, 2008, Obesity.

Mitochondrial Dysfunction Induced by Xenobiotics: Involvement in Steatosis and Steatohepatitis

B. Fromenty, K. Begriche, J. Massart, 2019, Mitochondria in Obesity and Type 2 Diabetes.

Effects of β‐aminoisobutyric acid on leptin production and lipid homeostasis: mechanisms and possible relevance for the prevention of obesity

B. Fromenty, J. Massart, Karima Begriche, 2009, Fundamental & clinical pharmacology.

Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids

D. Lagadic-Gossmann, B. Fromenty, C. Coulouarn, 2019, European Journal of Nutrition.

Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.

B. Fromenty, M. Robin, K. Begriche, 2011, Clinics and research in hepatology and gastroenterology.

Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease

B. Fromenty, A. Corlu, K. Begriche, 2022, International journal of molecular sciences.

Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease

B. Fromenty, F. Bonnet, M. Robin, 2013, Hepatology.

Bisphenol a induces steatosis in HepaRG cells using a model of perinatal exposure

D. Zalko, B. Fromenty, M. Robin, 2017, Environmental toxicology.

Mid-infrared fibre evanescent wave spectroscopy of serum allows fingerprinting of the hepatic metabolic status in mice.

S. Lardjane, V. Monbet, B. Fromenty, 2016, The Analyst.

Mitochondrial dysfunction in nonalcoholic steatohepatitis (NASH): are there drugs able to improve it?

B. Fromenty, M. Robin, K. Begriche, 2009 .

Drug-Induced Alterations of Mitochondrial DNA Homeostasis in Steatotic and Nonsteatotic HepaRG Cells

G. Labbe, B. Fromenty, A. Lombès, 2018, The Journal of Pharmacology and Experimental Therapeutics.

High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.

B. Fromenty, M. Robin, K. Begriche, 2008, Toxicology in vitro : an international journal published in association with BIBRA.

High Doses of Stavudine Induce Fat Wasting and Mild Liver Damage without Impairing Mitochondrial Respiration in Mice

D. Pessayre, B. Fromenty, G. Feldmann, 2006, Antiviral therapy.

The effect of water suppression on the hepatic lipid quantification, as assessed by the LCModel, in a preclinical and clinical scenario

B. Fromenty, H. Saint-Jalmes, G. Gambarota, 2016, Magnetic Resonance Materials in Physics, Biology and Medicine.

Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity

B. Fromenty, Simon Bucher, K. Begriche, 2020, Cell Biology and Toxicology.

Effects of Zidovudine, Stavudine and β-Aminoisobutyric Acid on Lipid Homeostasis in Mice: Possible Role in Human Fat Wasting

D. Pessayre, B. Fromenty, J. Bastin, 2004, Antiviral therapy.

Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis.

B. Fromenty, K. Begriche, J. Massart, 2020, Clinics and research in hepatology and gastroenterology.

Chronic exposure to low doses of pharmaceuticals disturbs the hepatic expression of circadian genes in lean and obese mice.

B. Fromenty, C. Coulouarn, S. Anthérieu, 2014, Toxicology and applied pharmacology.

Unravelling the mysterious roles of melanocortin-3 receptors in metabolic homeostasis and obesity using mouse genetics.

A. Ptitsyn, A. Butler, K. Begriche, 2014, International journal of obesity supplements.

Possible Involvement of Mitochondrial Dysfunction and Oxidative Stress in a Cellular Model of NAFLD Progression Induced by Benzo[a]pyrene/Ethanol CoExposure

D. Lagadic-Gossmann, B. Fromenty, Simon Bucher, 2018, Oxidative medicine and cellular longevity.

Differences in Early Acetaminophen Hepatotoxicity between Obese ob/ob and db/db Mice

Mitchell R. McGill, H. Jaeschke, B. Fromenty, 2012, Journal of Pharmacology and Experimental Therapeutics.

Mitochondrial, Metabolic and Genotoxic Effects of Antiretroviral Nucleoside Reverse-Transcriptase Inhibitors

D. Pessayre, B. Fromenty, Anissa Igoudjil, 2006 .

Melanocortin-3 receptors and metabolic homeostasis.

A. Butler, P. McDonald, K. Begriche, 2013, Progress in molecular biology and translational science.